Back
CVS Health Vs. Akero Therapeutics Industry Stock Comparison
Buy
58
CVS
CVS Health
Last Price:
$56.51
Seasonality Move:
6.43%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Buy
58
CVS Health (CVS)
is a Buy
Is CVS Health a Buy, Sell or Hold?
-
The current CVS Health [CVS] share price is $56.48. The Score for CVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
CVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.08. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $56.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVS is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
CVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.98 | Buy |
Relative Strength Index (14 RSI): | 69.4 | Buy |
Chaikin Money Flow: | -830789 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.52 - 54.98) | Buy |
Bollinger Bands (100): | (49.56 - 61.46) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.25 | Buy |
Relative Strength Index (14 RSI): | 82.91 | Buy |
Chaikin Money Flow: | -280479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.47 - 42.61) | Buy |
Bollinger Bands (100): | (24.31 - 36.07) | Buy |
CVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.64 | Buy |
20-day SMA: | 51.68 | Buy |
50-day SMA: | 51.95 | Buy |
200-day SMA: | 57.51 | Sell |
8-day EMA: | 55.54 | Buy |
20-day EMA: | 53.03 | Buy |
50-day EMA: | 52.61 | Buy |
200-day EMA: | 58.32 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43 | Buy |
20-day SMA: | 32.36 | Buy |
50-day SMA: | 31 | Buy |
200-day SMA: | 26.7 | Buy |
8-day EMA: | 45.65 | Buy |
20-day EMA: | 36.88 | Buy |
50-day EMA: | 32.36 | Buy |
200-day EMA: | 28.76 | Buy |
CVS Health Earnings Growth & CVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.86 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
CVS Health Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |